Journals / Ege Tıp Dergisi / 2019 / Cilt: 58 - Sayı: 4

The evaluation of serum asymmetric dimethyl arginine, fetuin-A and ankle-brachial index values in type 2 diabetic patients with and without microalbuminuria

Mikroalbüminürisi olan ve olmayan tip 2 diyabetik hastalarda serum asimetrik dimetil arjinin, fetuin-A ve ankle-brakial indeks değerlerinin değerlendirilmesi

Pages
397–405
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Based on our results, it can be suggested that serum asymmetric dimethyl arginine is superior to fetuin-A in patients with type 2 diabetes mellitus and microalbuminuria for atherosclerotic process.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: We aimed to compare atherosclerosis markers in patients with type 2 diabetes mellitus with and without microalbuminuria.
📊
Key Findings & Data:Material and Methods: Eighty type 2 diabetes mellitus patients with and without microalbuminuria aged between 40-60 years were enrolled in this study.
💡
Conclusion & Impact:Conclusion: Based on our results, it can be suggested that serum asymmetric dimethyl arginine is superior to fetuin-A in patients with type 2 diabetes mellitus and microalbuminuria for atherosclerotic process.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: We aimed to compare atherosclerosis markers in patients with type 2 diabetes mellitus with and without microalbuminuria. Material and Methods: Eighty type 2 diabetes mellitus patients with and without microalbuminuria aged between 40-60 years were enrolled in this study. Serum levels of asymmetric dimethylarginine, fetuin-A and laboratory parameters such as lipid profile and A1c were evaluated. Ankle-brachial indexes were measured. Results: No statistically significant correlation was found between microalbuminuria and total cholesterol, triglyceride, LDL cholesterol, HDL cholesterol, A1c, plasma fasting glucose, body mass index, anklebrachial index. Patients with microalbuminuria had significantly lower serum fetuin-A levels in comparison with subjects of non-microalbuminuria (p=0.008). However, a significant negative correlation was achieved between fetuin-A levels and microalbuminuria. We found that lower fetuin-A levels were associated with peripheric arterial disease, defined as anklebrachial index ≤ 0.9 (p=0.001). There was a statistically significant correlation between microalbuminuria and serum asymmetric dimethylarginine levels. Patients with microalbuminuria had significantly higher serum asymmetric dimethylarginine levels in comparison with subjects with non-microalbuminuria (p=0.013). Conclusion: Based on our results, it can be suggested that serum asymmetric dimethyl arginine is superior to fetuin-A in patients with type 2 diabetes mellitus and microalbuminuria for atherosclerotic process.

Özet

Amaç: Çalışmamızda mikroalbüminürisi olan ve olmayan tip 2 diabetes mellituslu hastalarda ateroskleroz belirteçlerini karşılaştırmayı amaçladık. Gereç ve Yöntem: Bu çalışmaya 40-60 yaşları arasında, tip 2 diyabetli mikroalbüminürik ve mikroalbuminürisi olmayan 80 hasta dahil edildi. Hastaların serum asimetrik dimetil arjinin, fetuin-A düzeyleri, lipit profili ile açlık ve tokluk glukoz, A1c gibi laboratuvar parametreleri değerlendirildi. Anklebrakiyal indeks (ABİ) ölçümleri yapıldı. Bulgular: Mikroalbüminüri ile total kolesterol, trigliserid, LDL kolesterol, HDL kolesterol, A1c, plazma açlık glukozu, vücut kitle indeksi, ankle-brakiyal indeksi arasında istatistiksel olarak anlamlı bir ilişki bulunmadı. mikroalbüminürisi olan hastalar mikroalbüminürisi olmayan hastalara göre anlamlı olarak daha düşük serum fetuin-A düzeylerine sahipti (p = 0,008). Ancak, fetuin-A düzeyleri ve mikroalbüminüri arasında anlamlı negatif korelasyon elde edildi. Düşük fetuin-A düzeylerinin, ABİ ≤ 0,9 olarak tanımlanan periferik arter hastalığı ile ilişkili olduğu belirlendi (p = 0,001). Mikroalbüminüri ve serum asimetrik dimetil arjinin düzeyleri arasında istatistiksel olarak anlamlı ilişki saptandı. Mikroalbüminürisi olan hastaların, olmayanlara göre anlamlı olarak daha yüksek serum asimetrik dimetil arjinin düzeylerine sahip olduğu belirlendi (p = 0,013). Sonuç: Çalışmamızın sonuçlarına göre, aterosklerotik süreçte tip 2 diabetes mellituslu mikroalbüminürisi olan hastalarda serum asimetrik dimetil arjininin fetuin-A'ya üstün olduğu ileri sürülebilir.

🔖

Cite This Article

KILAVUZ, A., GÖKER, B., SAVAŞ, S., AVCI, Ç. B., SARAÇ, F., GÜNDÜZ, C. (2019). The evaluation of serum asymmetric dimethyl arginine, fetuin-A and ankle-brachial index values in type 2 diabetic patients with and without microalbuminuria. Ege Tıp Dergisi, Cilt: 58 - Sayı: 4, 397–405. https://ajindex.com/articles/161340

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. David KM. Definition of diabetes mellitus. In: Rose BD (ed). Uptodate. Wellesley: 2009: 17 (1). [Cited 26 May 2018]. Available from:
  2. St Clair L, Ballantyne CM. Biological surrogates for enhancing cardiovascular risk prediction in type 2 diabetes mellitus. Am J Cardiol 2007; 99: 80B-8B
  3. Lorant DP, Grujicic M, Hoebaus C, et al. Fetuin-A levels are increased in patients with type 2 diabetes and peripheral arterial disease. Diabetes care 2011; 34: 156–61
  4. Roos M, Oikonomou D, von Eynatten M, et al. Associations of fetuin-A levels with vascular disease in type 2 diabetes patients with early diabetic nephropathy. Cardiovascular diabetology 2010; 9: 48
  5. Mogensen CE. Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas. Diabetologia 1999; 42: 263–85
  6. Garg JP, Bakris GL. Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease. Vascular medicine 2002; 7 (1): 35-43
  7. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin dependent diabetes mellitus: a systematic overview of the literature. Arch Intern Med 1997; 157: 1413-8
  8. Spittell JA Jr. Diagnosis and management of occlusive peripheral arterial disease. Curr Probl Cardiol 1990; 15: 1
  9. Resnick HE, Lindsay RS, McDermott MM, et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation 2004; 109: 733–9
  10. Barclay L, Vega C. Fetuin-A linked with incident diabetes. JAMA 2008; 300: 182-8
  11. Schafer C, Heiss A, Schwarz A, et al. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003; 112: 357–66
  12. Stefan N, Hennige AM, Staiger H, et al. Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes care 2006; 29: 853–7
  13. Hennige AM, Staiger H, Wicke C, et al. Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS One 2008; 3 (3): 1765
  14. Eraso LH, Ginwala N, Qasim AN, et al. Association of lower plasma fetuin-A levels with peripheral arterial disease in type 2 diabetes. Diabetes care 2010; 33: 408–10
  15. Krzyzanowska K, Mittermayer F, Shnawa N, et al. Asymmetrical dimethylarginine is related to renal function, chronic inflammation and macroangiopathy in patients with type 2 diabetes and